欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33931 篇 当前为第 336 页 共 3394

所属行业:医药制造业

  • 3351.2019互联网医疗行业洞察

    [医药制造业,信息传输、软件和信息技术服务业] [2020-01-10]

    『互联网医疗』行业背景:我国医疗服务总量不足。近年来我国医疗服务供给已逐步加大,但未来国民对医疗服务的需求将只增不减。

    关键词:2019;互联网医疗;行业洞察
  • 3352.《智能制造月度监测报告》2019年第7期

    [专用设备制造业,通用设备制造业,医药制造业,计算机、通信和其他电子设备制造业] [2020-01-10]

    本监测报告内容覆盖智能制造装备总体产业,包括智能测控装置、关键基础零部件、智能化高端装备和重大集成智能装备等智能制造装备的细分产业;以关键制造环节的智能化为核心,以端到端数据流为基础,和以网通互联为支撑。包括智能 产品、智能生产、智能工厂、智能物流、各类智能机器人等。

    关键词:智能制造;无人机;监测报告
  • 3353.全球患者门户市场-增长,趋势和预测(2019-2025年)

    [信息传输、软件和信息技术服务业,医药制造业] [2020-01-10]

    Evidence-based research studies on healthcare technologies indicated that the adoption of patient portals reached 90% in most of the developed countries. This means, 90% of the providers offer patient portals to their patients in the United States. However, there are still some unmet needs of the patients that require more actions, in order to drive the effective use of patient portals across the developing countries. Despite the higher adoption rate of patient portals, the number of patients that use the portal to take care of their health is low. According to a report published by the American Hospital Association (AHA), only 30% of the patients in the United States actively use patient portal. The scenario is similar in the European countries, such as Germany and France, where the adoption is higher, but the actual use is yet to reach the satisfactory percentage.

    关键词:医疗技术;患者门户网站;采用率;采取更多的行动;发展中国家;推动患者门户;有效使用;患者门户网站;采用率更高
  • 3354.全球孤儿药市场-增长,趋势和预测(2019-2024年)

    [医药制造业] [2020-01-10]

    Orphan drugs can be defined as a molecule intended to treat a rare disease. The rare disease, as name suggests, has low prevalence rate and has been defined differently across the geographical locations. Each country has at the least one organization, which has been supporting the patients suffering from rare diseases. The need is to generate enough orphan drugs’ availability to the needful for the intended treatment, across the world. From the company's perspective, there is increased focus by drug manufacturers, each year, on the development of therapies for orphan indications, as well as, explore the expansion opportunities across the world. The market report discusses the market aspects related to each market, segmentation, and major geographies across world. The market size can be evaluated by collating the revenues generated from various segments and their usage across the various end-user industries, along with the costs associated with products. The definitions for individual segments have been provided in the respective segments. The market estimates provided in this report are entirely based on the segments tracked in this report.

    关键词:孤儿药;旨在;治疗罕见疾病的分子;全球范围内;治疗方法;越来越重视;孤儿适应症疗法;开发;扩展机会;产品相关的成本;评估市场规模
  • 3355.全球医用电极市场-增长,趋势和预测(2019-2024年)

    [仪器仪表制造业,医药制造业] [2020-01-10]

    The market for medical electrodes is being driven by factors, such as the increasing prevalence of cardiovascular and neurological diseases, increasing investm ent for technological a dvancemen ts by biopharmaceutical companies, and rising focus toward minimally invasive surgeries. The rising population of the world is stimulating the demand for increased access and advancements in diagnostic technologies and treatment modalities. Due to the aging and rising world population, the demand for healthcare products and services increased by multiple times in the past decade, particularly in the developed and high-economic growth countries. The growing prevalence of cardiac and neurological diseases plays an essential role in the growth of the medical electrodes market.

    关键词:医用电极市场;诸多因素的推动;心血管疾病;神经疾病;流行;生物制药公司;投资不断增加;微创外科手术的关注;日益增加;诊断技术;治疗方式;获取和进步;需求;医疗保健产品;服务的需求;心脏和神经系统疾病的流行;医疗电极市场的增长;至关重要的作用
  • 3356.全球HPV测试和PAP测试市场-增长,趋势和预测(2019-2024年)

    [医药制造业] [2020-01-07]

    Pap and HPV tests are vital for diagnosis of cancers and precancer stages in cervix. Mostly these tests are performed together for the patient age group between 21-65 years. As per the international Agency for Research on Cancer, more than 85% of cervical cancer patients are from the developing countries, which demands better efficacy screening and treatment programs for women’s health. Since the cancer progression is slow and may take up to 20 years to develop into an advanced stage, there are many opportunities to stop the disease before it becomes fatal. At present, there are many cities in the emerging market that lack resources for a good laboratory with highly trained cytotechnicians and other specialized staff, which is among the major challenges for good results from Pap testing. With the advancement of HPV tests, the prevention possibility of expansion of cervical cancers increases even in the low resource settings because it is a more affordable and cost-effective strategy, leveraging self-sampling potentially. There are countries, such as Australia and New Zealand, which have effectively taken positive measures related to proper HPV and Pap testing to eradicate cervical cancer. However, the current scenario demands more countries to take better initiatives to roll out the advanced screening tests of HPV and Pap through financial support from the government.

    关键词:子宫颈抹片检查;HPV检测;宫颈癌;癌前分期;诊断;女性健康;功效筛查;治疗计划;专门人员;优质实验室;巴氏检测;更实惠;更具成本效益
  • 3357.山西整治假中药不手软

    [医药制造业,公共管理、社会保障和社会组织] [2020-01-06]

    关键词:山西;整治;假中药;
  • 3358.医药生物行业:或科技属性偏强、消费属性偏弱-2020年投资策略

    [医药制造业] [2020-01-05]

    经济弱复苏,资金面偏宽松。股市进入全面牛,医药在消费与科技属性上,或科技属性偏强,消费属性偏弱。消费股的大牛市一般在熊末牛初,这阶段市场沉浸在对未来不确定性上,寻找确定性,抱团取暖消费。


    关键词:医药生物行业;2020年;投资策略
  • 3359.医药生物行业:肝癌药物治疗及药物研发现状

    [医药制造业] [2020-01-05]

    肝癌是全球常见恶性肿瘤之一,其中肝细胞癌(HCC)约占90%以上。肝癌的发病率逐年升高,已成为第6位常见的恶性肿瘤,且其恶性程度高,在肿瘤相关病死率中居第2位。


    关键词:医药生物行业;肝癌;药物治疗;研发现状
  • 3360.医药生物行业:艾司氯胺酮上市,麻醉镇痛再添新品-专题研究

    [医药制造业] [2020-01-05]

    住院病人手术量稳定增长以及镇痛需求释放,麻醉镇痛成为高景气细分药品领域之一。 根据2019 年卫生统计年鉴披露的数据,2018 年我国住院病人手术量6171.58 万人次,近三年年增长率在10%以上。


    关键词:医药生物行业;艾司氯胺酮上;麻醉镇痛;专题研究
首页  上一页  ...  331  332  333  334  335  336  337  338  339  340  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服